247 related articles for article (PubMed ID: 37569265)
21. Prognostic and Clinicopathological Significance of Telomerase Reverse Transcriptase Upregulation in Oral Cancer: A Systematic Review and Meta-Analysis.
González-Moles MÁ; Moya-González E; García-Ferrera A; Nieto-Casado P; Ramos-García P
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954336
[TBL] [Abstract][Full Text] [Related]
22. The primary site of head and neck squamous cell carcinoma predicts survival benefits of EGFR inhibitors: A systematic review and meta-analysis.
Nie D; Wang X; Sun M; Feng Z; Pei F; Liu W; Wang Z; Han F
Radiother Oncol; 2021 May; 158():13-20. PubMed ID: 33587969
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer.
Zanotti L; Paderno A; Piazza C; Pagan E; Bignotti E; Romani C; Bandiera E; Calza S; Del Bon F; Nicolai P; Ravaggi A
Laryngoscope; 2017 Nov; 127(11):E408-E414. PubMed ID: 28782189
[TBL] [Abstract][Full Text] [Related]
24. Combined cytoplasmic and membranous EGFR and p53 overexpression is a poor prognostic marker in early stage oral squamous cell carcinoma.
Monteiro LS; Diniz-Freitas M; Garcia-Caballero T; Warnakulasuriya S; Forteza J; Fraga M
J Oral Pathol Med; 2012 Aug; 41(7):559-67. PubMed ID: 22417132
[TBL] [Abstract][Full Text] [Related]
25. Cyclin D1 overexpression is associated with poor clinicopathological outcome and survival in oral squamous cell carcinoma in Asian populations: insights from a meta-analysis.
Zhao Y; Yu D; Li H; Nie P; Zhu Y; Liu S; Zhu M; Fang B
PLoS One; 2014; 9(3):e93210. PubMed ID: 24675814
[TBL] [Abstract][Full Text] [Related]
26. Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
Qian G; Jiang N; Wang D; Newman S; Kim S; Chen Z; Garcia G; MacBeath G; Shin DM; Khuri FR; Chen ZG; Saba NF
Cancer; 2015 Oct; 121(20):3600-11. PubMed ID: 26195293
[TBL] [Abstract][Full Text] [Related]
27. Tumor epidermal growth factor receptor and EGFR PY1068 are independent prognostic indicators for head and neck squamous cell carcinoma.
Wheeler S; Siwak DR; Chai R; LaValle C; Seethala RR; Wang L; Cieply K; Sherer C; Joy C; Mills GB; Argiris A; Siegfried JM; Grandis JR; Egloff AM
Clin Cancer Res; 2012 Apr; 18(8):2278-89. PubMed ID: 22351687
[TBL] [Abstract][Full Text] [Related]
28. Predictive Prognostic Value of Tissue-Based MicroRNA Expression in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.
Troiano G; Mastrangelo F; Caponio VCA; Laino L; Cirillo N; Lo Muzio L
J Dent Res; 2018 Jul; 97(7):759-766. PubMed ID: 29533734
[TBL] [Abstract][Full Text] [Related]
29. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
[TBL] [Abstract][Full Text] [Related]
30. The Prognostic Value of Human Papilloma Virus Infection in Oral Cavity Squamous Cell Carcinoma: A Meta-Analysis.
Christianto S; Li KY; Huang TH; Su YX
Laryngoscope; 2022 Sep; 132(9):1760-1770. PubMed ID: 34953144
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Impact of Epidermal Growth Factor Receptor Overexpression in Patients with Cervical Cancer: A Meta-Analysis.
Tian WJ; Huang ML; Qin QF; Chen Q; Fang K; Wang PL
PLoS One; 2016; 11(7):e0158787. PubMed ID: 27438047
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of CircRNAs expression in oral squamous cell carcinoma.
Zhang L; Wang M; Ren W; Li S; Zhi K; Gao L; Zheng J
Oral Dis; 2023 May; 29(4):1439-1453. PubMed ID: 35286741
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in South Asian head and neck squamous cell carcinoma: association with various risk factors and clinico-pathologic and prognostic parameters.
Hashmi AA; Hussain ZF; Aijaz S; Irfan M; Khan EY; Naz S; Faridi N; Khan A; Edhi MM
World J Surg Oncol; 2018 Jun; 16(1):118. PubMed ID: 29954411
[TBL] [Abstract][Full Text] [Related]
34. EGFR-mediated signaling pathway influences the sensitivity of oral squamous cell carcinoma to JQ1.
Liu X; Li Q; Huang P; Tong D; Wu H; Zhang F
J Cell Biochem; 2018 Oct; 119(10):8368-8377. PubMed ID: 30687956
[TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor/epidermal growth factor receptor signaling blockage inhibits tumor cell-derived exosome uptake by oral squamous cell carcinoma through macropinocytosis.
Sasabe E; Tomomura A; Liu H; Sento S; Kitamura N; Yamamoto T
Cancer Sci; 2022 Feb; 113(2):609-621. PubMed ID: 34874595
[TBL] [Abstract][Full Text] [Related]
36. Prognostic and Clinicopathological Significance of the Loss of Expression of Retinoblastoma Protein (pRb) in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
López-Ansio M; Ramos-García P; González-Moles MÁ
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370742
[TBL] [Abstract][Full Text] [Related]
37. Relationship of programmed death ligand-1 expression with clinicopathological features and prognosis in patients with oral squamous cell carcinoma: A meta-analysis.
He J; Chen XF; Xu MG; Zhao J
Arch Oral Biol; 2020 Jun; 114():104717. PubMed ID: 32344357
[TBL] [Abstract][Full Text] [Related]
38. Human epidermal growth factor receptor 2, epidermal growth factor receptor, and c-MET overexpression and survival in biliary tract cancer: A meta-analysis.
Zhou W; Jiang C; Zhan N; Lv X; Fan L; Ninu M
J Cancer Res Ther; 2018; 14(Supplement):S28-S35. PubMed ID: 29578146
[TBL] [Abstract][Full Text] [Related]
39. Effect of EGFR on SQSTM1 Expression in Malignancy and Tumor Progression of Oral Squamous Cell Carcinoma.
Tseng YK; Chen CF; Shu CW; Lee CH; Chou YT; Li YJ; Liou HH; Cheng JT; Chen CL; Ger LP; Liu PF
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830108
[TBL] [Abstract][Full Text] [Related]
40. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]